OBJECTIVE: There are no specific biomarkers available for the definitive diagnosis of pancreatic cancer. Analysis of D-glucuronic acid (GlcUA) in bile could be valuable in this regard. MATERIALS AND METHODS: Bile samples obtained from patients with pancreatic cancer (n = 4), chronic pancreatitis (n = 3) and control patients with biliary obstruction (n = 10) were analyzed by (1)H NMR spectroscopy. GlcUA was quantified from the peak area of the alpha-(1)CH signal (at 5.24 ppm) obtained by deconvolution. RESULTS: GlcUA was detected in human bile by one-dimensional (1)H NMR and two-dimensional (1)H-(1)H COSY and TOCSY experiments. Quantification of GlcUA was achieved by measuring the peak area of the alpha-(1)CH signal using CPMG experiment, and the quantities of GlcUA were calibrated to account for the attenuation due to T (2) relaxation. GlcUA was observed at elevated levels in bile samples obtained from pancreatic cancer patients, whereas it was either absent or found in negligible amounts in control and chronic pancreatitis patients. The reason for the presence of elevated levels of GlcUA could be the hydrolysis of biliary bilirubin diglucuronide by beta-glucuronidase, released excessively from pancreatic tissue during the course of malignancy. CONCLUSION: Analysis of D-glucuronic acid in bile could be valuable in the detection of pancreatic cancer, and detecting GlcUA by in vivo (1)H MRS has the potential to help in the non-invasive diagnosis of pancreatic cancer. Given that only four cancer patients have been studied so far, the new biomarker is regarded as a preliminary finding, but one that warrants further investigation.
OBJECTIVE: There are no specific biomarkers available for the definitive diagnosis of pancreatic cancer. Analysis of D-glucuronic acid (GlcUA) in bile could be valuable in this regard. MATERIALS AND METHODS: Bile samples obtained from patients with pancreatic cancer (n = 4), chronic pancreatitis (n = 3) and control patients with biliary obstruction (n = 10) were analyzed by (1)H NMR spectroscopy. GlcUA was quantified from the peak area of the alpha-(1)CH signal (at 5.24 ppm) obtained by deconvolution. RESULTS:GlcUA was detected in human bile by one-dimensional (1)H NMR and two-dimensional (1)H-(1)H COSY and TOCSY experiments. Quantification of GlcUA was achieved by measuring the peak area of the alpha-(1)CH signal using CPMG experiment, and the quantities of GlcUA were calibrated to account for the attenuation due to T (2) relaxation. GlcUA was observed at elevated levels in bile samples obtained from pancreatic cancerpatients, whereas it was either absent or found in negligible amounts in control and chronic pancreatitispatients. The reason for the presence of elevated levels of GlcUA could be the hydrolysis of biliary bilirubindiglucuronide by beta-glucuronidase, released excessively from pancreatic tissue during the course of malignancy. CONCLUSION: Analysis of D-glucuronic acid in bile could be valuable in the detection of pancreatic cancer, and detecting GlcUA by in vivo (1)H MRS has the potential to help in the non-invasive diagnosis of pancreatic cancer. Given that only four cancerpatients have been studied so far, the new biomarker is regarded as a preliminary finding, but one that warrants further investigation.
Authors: M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui Journal: J Natl Cancer Inst Date: 2001-07-18 Impact factor: 13.506
Authors: N Albiin; I C P Smith; U Arnelo; B Lindberg; A Bergquist; B Dolenko; N Bryksina; T Bezabeh Journal: Acta Radiol Date: 2008-10 Impact factor: 1.990
Authors: Shahid A Khan; I Jane Cox; Andrew V Thillainayagam; Devinder S Bansi; Howard C Thomas; Simon D Taylor-Robinson Journal: Eur J Gastroenterol Hepatol Date: 2005-07 Impact factor: 2.566
Authors: Anatoly I Masyuk; Tatyana V Masyuk; Pamela S Tietz; Patrick L Splinter; Nicholas F LaRusso Journal: Am J Physiol Cell Physiol Date: 2002-09 Impact factor: 4.249
Authors: Omkar B Ijare; Tedros Bezabeh; Nils Albiin; Urban Arnelo; Annika Bergquist; Bo Lindberg; Ian C P Smith Journal: NMR Biomed Date: 2009-06 Impact factor: 4.044
Authors: Amar W Sharif; Horace R T Williams; Temi Lampejo; Shahid A Khan; Devinder S Bansi; David Westaby; Andrew V Thillainayagam; Howard C Thomas; I Jane Cox; Simon D Taylor-Robinson Journal: HPB (Oxford) Date: 2010-08 Impact factor: 3.647
Authors: Mohammed A Alshehri; Moath M Alshehri; Naif N Albalawi; Moshari A Al-Ghamdi; Mohammed M H Al-Gayyar Journal: Oncol Lett Date: 2021-01-04 Impact factor: 2.967